C07K 16/248
Il-6
Official title: {il-6}
C07K16/248 (Il-6) appears on 378 US grants and 703 published applications in this corpus.
Search patents in C07K- Granted patents
- 378
- Published applications
- 703
- Assignees
- 287
- Inventors
- 1,107
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 3 |
| 2003 | 3 | 7 |
| 2004 | 4 | 7 |
| 2005 | 2 | 9 |
| 2006 | 3 | 16 |
| 2007 | 4 | 14 |
| 2008 | 2 | 22 |
| 2009 | 10 | 23 |
| 2010 | 5 | 25 |
| 2011 | 14 | 21 |
| 2012 | 14 | 30 |
| 2013 | 15 | 33 |
| 2014 | 14 | 33 |
| 2015 | 19 | 37 |
| 2016 | 26 | 40 |
| 2017 | 39 | 40 |
| 2018 | 29 | 44 |
| 2019 | 23 | 47 |
| 2020 | 17 | 38 |
| 2021 | 26 | 40 |
| 2022 | 20 | 50 |
| 2023 | 15 | 42 |
| 2024 | 26 | 33 |
| 2025 | 13 | 26 |
| 2026 | 13 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Controlled release of antibodies to modulate cytokines8 Sep 2026US 12,729,237 B2Flow Pharma, Inc.
- Methods of administering chimeric antigen receptor immunotherapy25 Aug 2026US 12,715,925 B2Kite Pharma, Inc.
- Methods of administering chimeric antigen receptor immunotherapy18 Aug 2026US 12,709,639 B2Kite Pharma, Inc.
- Composition for cancer diagnosis18 Aug 2026US 12,710,425 B2Acurasysbio Co., Ltd.
- Methods of modifying antibodies for purification of bispecific antibodies28 Jul 2026US RE50,968 E1Chugai Seiyaku Kabushiki Kaisha
- Engineered bispecific molecules and methods of use10 Sep 2026US 2026/0265389 A1Cantai Therapeutics Inc.
- Anti-pd-1 chimeric antigen receptor t cells and therapeutic uses thereof20 Aug 2026US 2026/0240908 A1Fred Hutchinson Cancer Center
- Interleukin-6 (il-6)/signal transducer and activator of transcription 3 (stat3) pathway inhibitors for use in the treatment of granulomatous diseases30 Jul 2026US 2026/0216107 A1UCL Business PLC
- Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly30 Jul 2026US 2026/0217808 A1Chugai Seiyaku Kabushiki Kaisha
- Methods for the treatment of noninfectious uveitis30 Jul 2026US 2026/0217817 A1
Most cited
By later US patents
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Human antibodies derived from immunized xenomice1,057US 6,075,181 AAbgenix, Inc. · 2000
- Human antibodies derived from immunized xenomice943US 6,150,584 AAbgenix, Inc. · 2000
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000
- Generation of Xenogenetic antibodies561US 6,162,963 AAbgenix, Inc. · 2000